LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Primo Brands Corporation (PRMB) Shareholders To Inquire About Securities Fraud Class Action.

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Successful passive income investing doesn't have to be overly expensive or labor-intensive.

Cloudflare was hit by an outage that knocked several major websites and services offline for several hours. Many sites came back online within a few hours.

CNBC's Deirdre Bosa joins 'Money Movers' with the latest Tech Check.

Plains GP Holdings (PAGP) is rated a Buy, driven by strategic asset sales, oil-focused growth, and anticipated oil market recovery. PAGP's divestiture of its $3.75B gas business and acquisitions like EPIC Crude Holdings streamline operations and boost oil delivery capacity. Q3 2025 results show rising oil EBITDA, strong cash flow, and reaffirmed 2025 guidance, highlighting PAGP's operational stability and financial flexibility.

Forecasts GSV acceleration and double-digit compound annual growth rates for revenue, adjusted EBITDA through 2028 Growth strategy doubles down on strong AI tailwind, accelerating traction with SMBs, and unlocking Enterprise expansion PALO ALTO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world's human and AI-powered work marketplace, today outlined its long-term growth strategy and financial outlook at its 2025 Investor Day.

Shares of Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) soared Tuesday in reaction to Roche Holdings AG‘s (OTC: RHHBY) phase 3 results from the lidERA Breast Cancer study of giredestrant in early-stage breast cancer.

MVST's Q3 revenues jump 21.6% YoY as demand for advanced batteries rises across key regions, led by strong EMEA gains.

MKC posts its fifth straight quarter of volume-led growth as consumer demand and brand investment offset tariff and cost pressures.

PFE trades above its 50-day SMA on recent gains from the Metsera acquisition and a drug pricing agreement with the U.S. administration.

Richtech Robotics shifts to a RaaS model, trading short-term revenue softness for recurring MSAs and strong margins as its long-term growth strategy takes shape.

Zscaler is rated Buy, with a suggested stop at $258, offering a 2:1 to 3.3:1 risk/reward from current levels. ZS fundamentals remain strong: 21% YoY revenue growth, stable margins, and nearly $2bn net cash, justifying its premium valuation. Despite high valuation multiples, ZS is outperforming software peers, reflecting confidence in cybersecurity demand amid AI and datacenter growth.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Six Flags Entertainment Corporation (“Six Flags” or the “Company”) (NYSE: FUN) common stock pursuant or traceable to the Company's registration statement and prospectus issued in connection with the July 1, 2024 merger of Six Flags with Cedar Fair, L.P. (“Cedar Fair”), and their subsidiari.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB) investors who purchased or otherwise acquired: (1) Primo Water Corporation (“Primo Water”) common stock between June 17, 2024 and November 8, 2024, inclusive; and/or (2) Primo Brands common stock between November 11, 2024 and November 6, 2025, inclusive (the “Class Period”). Primo Brands investors.

BENSALEM, Pa., Nov. 18, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX).

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR STRIDE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER.

BURLINGTON, Mass.--(BUSINESS WIRE)-- #ADCs--Lifordi Immunotherapeutics, Inc., a clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, today announced a strategic investment from Sanofi Ventures, the venture arm of global healthcare leader Sanofi, and funding from existing investors ARCH Ventures, 5AM Ventures, and Atlas Venture. The new funds bring the total raised to $112 million and support an ongoing Phase 1 study in Rhe.

LOS ANGELES , Nov. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX) have opportunity to lead the securities fraud class action lawsuit.

LOS ANGELES , Nov. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Avantor, Inc. ("Avantor" or the "Company") (NYSE: AVTR) have opportunity to lead the securities fraud class action lawsuit.